|
Title
|
|
|
|
Lung cancer screening in Europe : where are we in 2021?
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| This manuscript reviews the recent evidence obtained in lung cancer screening with low dose spiral CT-scan (LDSCT) and focuses on the issues associated with its implementation in Europe. After a review of the magnitude of the lung cancer toll in lives, disease and Euro's, the recently released data of the major lung cancer screening trials are reviewed and mirrored with the results of the US National Lung Screening Trial (NLST), comparing their strengths and weaknesses and areas of future research. The specific barriers and hurdles to be addressed for widely implementing this population screening in European countries are discussed, with special emphasis on the issues of inclusion of smokers, smoking cessation interventions, radiation injury and capacity planning. The pros and cons of including current smokers will be addressed together with the issue which is the better smoking cessation intervention. A medical physicist's view on radiation exposure and quality control will address concerns about radiation induced cancers. The downstream effects of a LDSCT screening program on the capacity of CT-scans, radiologists, thoracic surgeons and radiation oncologists will follow. An estimated roadmap for the future is sketched with the expected role of all key stakeholders. This roadmap reflects the opinion leader's reflections as expressed in a number of discussions with European health authorities, taking place as part of the recently released European Beating Cancer plan. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Translational lung cancer research. - -
|
|
|
Publication
|
|
|
|
Shatin
:
Ame publ co
,
2021
|
|
|
ISSN
|
|
|
|
2218-6751
|
|
|
DOI
|
|
|
|
10.21037/TLCR-20-890
|
|
|
Volume/pages
|
|
|
|
10
:5
(2021)
, p. 2407-2417
|
|
|
ISI
|
|
|
|
000670781700026
|
|
|
Pubmed ID
|
|
|
|
34164288
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (open access)
|
|
|
|
|
|